| Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study H Sorbye, S Welin, SW Langer, LW Vestermark, N Holt, P Osterlund, ... Annals of oncology 24 (1), 152-160, 2013 | 1044 | 2013 |
| Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic … KM Tveit, T Guren, B Glimelius, P Pfeiffer, H Sorbye, S Pyrhonen, ... J Clin Oncol 30 (15), 1755-1762, 2012 | 667 | 2012 |
| Identification of serum microRNA profiles in colon cancer E Hofsli, W Sjursen, WS Prestvik, J Johansen, M Rye, G Tranø, ... British journal of cancer 108 (8), 1712-1719, 2013 | 102 | 2013 |
| Reversal of multidrug resistance by lipophilic drugs E Hofsli, J Nissen-Meyer Cancer research 50 (13), 3997-4002, 1990 | 102 | 1990 |
| Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010 MG Guren, H Kørner, F Pfeffer, TÅ Myklebust, MT Eriksen, TH Edna, ... Acta oncologica 54 (10), 1714-1722, 2015 | 94 | 2015 |
| Identification of novel neuroendocrine-specific tumour genes E Hofsli, TE Wheeler, M Langaas, A Laegreid, L Thommesen British journal of cancer 99 (8), 1330-1339, 2008 | 81 | 2008 |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms A Venizelos, H Elvebakken, A Perren, O Nikolaienko, W Deng, IMB Lothe, ... Endocrine-related cancer 29 (1), 1-14, 2022 | 80 | 2022 |
| Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a … SB Winther, G Liposits, H Skuladottir, E Hofsli, CH Shah, LØ Poulsen, ... The lancet Gastroenterology & hepatology 4 (5), 376-388, 2019 | 61 | 2019 |
| Tumor necrosis factor-induced expression of platelet-derived growth factor A-chain messenger RNA in fibroblasts Y Paulsson, R Austgulen, E Hofsli, CH Heldin, B Westermark, ... Experimental cell research 180 (2), 490-496, 1989 | 57 | 1989 |
| Reversal of drug resistance by erythromycin: Erythromycin increases the accumulation of actinomycin d and doxorubicin in multidrug‐resistant cells E Hofsli, J Nissen‐meyer International journal of cancer 44 (1), 149-154, 1989 | 54 | 1989 |
| Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population‐based study G Tranø, HH Wasmuth, W Sjursen, E Hofsli, LJ Vatten Colorectal Disease 11 (5), 456-461, 2009 | 53 | 2009 |
| Discrimination of Patients with Microsatellite Instability Colon Cancer using 1H HR MAS MR Spectroscopy and Chemometric Analysis MB Tessem, KM Selnæs, W Sjursen, G Tranø, GF Giskeødegård, ... Journal of proteome research 9 (7), 3664-3670, 2010 | 50 | 2010 |
| Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian … G Tranø, W Sjursen, HH Wasmuth, E Hofsli, LJ Vatten British journal of cancer 102 (3), 482-488, 2010 | 50 | 2010 |
| A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes EVA Hofsli, O Bakke, U Nonstad, T Espevik Cellular immunology 122 (2), 405-415, 1989 | 46 | 1989 |
| Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location R Mjelle, W Sjursen, L Thommesen, P Sætrom, E Hofsli BMC cancer 19, 1-12, 2019 | 39 | 2019 |
| Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug‐resistant cells: Reversal of drug resistance by erythromycin E Hofsli, J Nissen‐Meyer International journal of cancer 43 (3), 520-525, 1989 | 38 | 1989 |
| Evidence that tumour necrosis factor (TNF) is not constitutively present in vivo the association of TNF with freshly isolated monocytes reflects a rapid in vitro production E Hofsli, J Lamvik, J Nissen‐Meyer Scandinavian journal of immunology 28 (4), 435-441, 1988 | 35 | 1988 |
| Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells E Hofsli, L Thommesen, K Nørsett, S Falkmer, U Syversen, AK Sandvik, ... Molecular and cellular endocrinology 194 (1-2), 165-173, 2002 | 32 | 2002 |
| Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells E Hofsli, L Thommesen, F Yadetie, M Langaas, W Kusnierczyk, U Falkmer, ... British journal of cancer 92 (8), 1506-1516, 2005 | 29 | 2005 |
| Identification of metastasis-associated microRNAs in serum from rectal cancer patients R Mjelle, K Sellæg, P Sætrom, L Thommesen, W Sjursen, E Hofsli Oncotarget 8 (52), 90077, 2017 | 23 | 2017 |
